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Dengue is considered a major international public health
concern. It is caused by any of the four dengue virus serotypes
(DEN-1 to 4), a RNA virus of the family Flaviviridae. Dengue
can result in a broad spectrum of diseases, ranging from a
self-limited sickness, dengue fever, to a severe and poten-
tially fatal disease, dengue hemorrhagic fever/dengue shock
syndrome (DHF/DSS). Unfortunately, case fatality rates can
exceed 20% if the correct therapy is not selected rapidly.1,2
A growing body of evidence has demonstrated that the
pathogenesis of DHF/DSS is a complex and multifactorial
process involving viral, immunological and host factors.1—3
Secondary dengue infections have been shown to be the most
important single risk factor for DHF/DSS,1,2 even 20 years or
more after contracting the disease.4,5 Individuals with certain
chronic conditions, such as sickle cell disease (SCD), are
probably at increased risk.1,3,4 Very recently, apoptotic cell
death in neuronal cells, leukocytes and endothelial cells (ECs)
of blood microvessels was demonstrated for the first time in
fatalDHF/DSScausedbyDEN-2 inCuba.Remarkably, apoptotic
ECs were probably associated with vascular leakage.6
In this study,wereport two(casesAandB)outof threeadult
fatal dengue cases from the DEN-3 Havana epidemic of 2001—
2002,4 after informedconsentwasobtained fromthedeceased
patients’ next-of-kin. Notably, both patients suffered from
SCD4 and presented grade IV DHF/DSS (following the World
Health Organization case definition).7 A secondary dengue
infection was confirmed serologically in both cases. In case
A, DEN-3 was isolated in mosquito cell culture C6/36-HT from
the patient’s serum, fresh liver and spleen tissue specimens;
viral RNAwas also detected from fresh liver and spleen tissue.
DEN-3 multiplication in the same mosquito cell line and viral
RNA was demonstrated in case B from a serum sample.
A cell death assay using the terminal deoxynucleotidyl
transferase mediated dUTP nick-end labeling (TUNEL)
method (In Situ Cell Death Detection Kit, Roche Applied
Science) was carried out on formalin-fixed, paraffin-
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nohistochemical assay for dengue antigen localization6 was
also performed. In both subjects, no DEN antigens were
detected in the tissues, but apoptotic neuronal cells in case
A. Despite vascular leakage (ascites) in the same patient,
apoptosis in ECs of the intestinal microvasculature was not
observed.
Previouswork demonstrated apoptotic hepatocytes in Viet-
namese childrenwhodiedofDHF/DSScausedbyDEN-3.8 In this
work, we demonstrate cell death in the neurons of a fatal
severe DEN-3 case. To our knowledge, apoptosis in the neurons
of a DEN-3 fatality has not been previously reported. In spite of
an in vitro study suggesting that sickle cell hemoglobin might
be neurotoxic and thus induce neuronal apoptosis,9 we can not
exclude that, similar to our previous report concerning non-
SCD patients,6 a metabolic/vascular-mediated mechanism
might be involved in the neuronal apoptotic pathway. Inter-
estingly, we could not show DEN antigen in the brain tissues of
fatal cases in our previous and current studies.
Whether immunopathological features of SCD participate
in the increased risk of severe DHF/DSS still needs further
investigation. Some studies suggest that activated mono-
cytes in SCD might activate ECs through different cytokines
that contribute to frequent SCD microvascular occlusions,10
altering EC apoptosis, immune responses and hemopoiesis.11
More detailed investigations are needed to elucidate the
association of apoptosis with severe dengue physiopathology
and non-infectious co-morbidities.
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